Schizoaffective Disorders Completed Phase 2 Trials for Progesterone (DB00396)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00206544Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?Treatment